RAB11A and chronic myelogenous leukemia, BCR-ABL1 positive: The evaluation of the AuNP@RAB11 silencing efficiency was assessed on the CML cell line K562, before and after incubation with the AuNP@RAB11A nanoformulation via quantification of RAB11A mRNA expression, Rab11a protein expression, and by examining the exosome secretion.